Business Description
![Novacyt SA Novacyt SA logo](https://static.gurufocus.com/logos/0C00009EWE.png?14)
Novacyt SA
ISIN : FR0010397232
Compare
Compare
Traded in other countries / regions
ALNOV.FranceNCYT.UKNYZ.GermanyNVYTF.USA IPO Date
2020-01-31Description
Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. The company operates its business through the following business segments: Primer Design, IT-IS International, Lab21 Products, Corporate, Yourgene Health and Intercompany eliminations. Majority of the revenue is generated from Yourgene Health segment.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.22 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.16 | |||||
Debt-to-EBITDA | -0.75 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 1.14 | |||||
Beneish M-Score | -1.62 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -65.2 | |||||
3-Year Book Growth Rate | -15.3 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.92 | |||||
9-Day RSI | 98.98 | |||||
14-Day RSI | 97.15 | |||||
6-1 Month Momentum % | -0.48 | |||||
12-1 Month Momentum % | -26.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.92 | |||||
Quick Ratio | 2.82 | |||||
Cash Ratio | 1.49 | |||||
Days Inventory | 131.47 | |||||
Days Sales Outstanding | 812.13 | |||||
Days Payable | 45.58 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -8.03 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 32.23 | |||||
Operating Margin % | -156.9 | |||||
Net Margin % | -244.35 | |||||
FCF Margin % | -221.66 | |||||
ROE % | -27.49 | |||||
ROA % | -20.93 | |||||
ROIC % | -27.92 | |||||
ROC (Joel Greenblatt) % | -126.9 | |||||
ROCE % | -25.47 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.17 | |||||
PB Ratio | 0.82 | |||||
Price-to-Tangible-Book | 1.29 | |||||
EV-to-EBIT | -1.45 | |||||
EV-to-EBITDA | -2.22 | |||||
EV-to-Revenue | 3.49 | |||||
EV-to-FCF | -1.58 | |||||
Price-to-Projected-FCF | 0.46 | |||||
Price-to-Median-PS-Value | 5.43 | |||||
Price-to-Net-Current-Asset-Value | 1.79 | |||||
Earnings Yield (Greenblatt) % | -68.97 | |||||
FCF Yield % | -36.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NVYTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Novacyt SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 14.646 | ||
EPS (TTM) ($) | -0.506 | ||
Beta | 0.45 | ||
Volatility % | 56.55 | ||
14-Day RSI | 97.15 | ||
14-Day ATR ($) | 0.038725 | ||
20-Day SMA ($) | 0.72644 | ||
12-1 Month Momentum % | -26.81 | ||
52-Week Range ($) | 0.5 - 1.25 | ||
Shares Outstanding (Mil) | 70.63 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Novacyt SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Novacyt SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Novacyt SA Frequently Asked Questions
What is Novacyt SA(NVYTF)'s stock price today?
The current price of NVYTF is $1.25. The 52 week high of NVYTF is $1.25 and 52 week low is $0.50.
When is next earnings date of Novacyt SA(NVYTF)?
The next earnings date of Novacyt SA(NVYTF) is 2024-09-27 Est..
Does Novacyt SA(NVYTF) pay dividends? If so, how much?
Novacyt SA(NVYTF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |